Mr. Robert Kaul reports

CLOUD DX WINS COMPETITIVE RFP, SIGNS CONTRACT WITH ALBERTA HEALTH SERVICES

Cloud Dx Inc. has been selected through a competitive RFP (request for proposal) process as a provider of digital remote patient monitoring (dRPM) products and services to Alberta Health Services (AHS).

AHS has deployed the Cloud Dx Connected Health platform since May, 2020, under a series of contracts signed during and after the COVID pandemic. Now, Cloud Dx has won the competitive RFP to continue as a provider of dRPM devices and services to the provincial health authority.

Digital remote patient monitoring is used generally to support outcomes for patients with complex chronic conditions that include chronic obstructive pulmonary disease (COPD), congestive heart failure (CHF) and co-morbidities, including hypertension, obesity and diabetes.

Connected Health by Cloud Dx includes its award-winning, patient-facing mobile application, easy-to-use Health Canada-licensed medical devices, smart software that gathers data from and connects to each patient at home, and comprehensive clinical workflows that improve both the efficiency of care delivery and health care outcomes for patients.

Clients across North America now deploy Cloud Dx Connected Health for chronic disease management, postsurgical monitoring, pulmonary and cardiac rehabilitation, diabetes, and palliative care use cases.

dRPM using Cloud Dx Connected Health has been shown, most recently in the peer-reviewed PCV-RAM-1 study, to dramatically reduce postsurgical medication errors, severe pain scores, ER (emergency room) visits and hospital readmissions.

According to official stats from the Canadian Institute for Health Information patient cost estimator, exacerbation of chronic conditions resulted in over 11,000 hospital admissions in Alberta in 2021, averaging approximately seven days each.

Recent research, including a series of studies at Hamilton Health Sciences in Hamilton, Ont., has shown that dRPM using Cloud Dx Connected Health can reduce the average length of a hospital admission by 1.9 days on average.

Cloud Dx is SOC 2 (Service Organization Control Type 2) compliant, and meets or exceeds Alberta Health Information Act (HIA) privacy and security regulations protecting personal health information.

This is the 21st contract or extension announced so far in 2023 by Cloud Dx versus 28 contracts/extensions announced in all of 2022.

Robert Kaul, founder and chief executive officer of Cloud Dx, stated: "Cloud Dx is very pleased to have been awarded this competitive dRPM contract with Alberta Health Services. Combined with the recently announced contract awards from Alberta Central Zone Primary Care Network and the Mohawk Medbuy shared services organization, Connected Health by Cloud Dx is now, more than ever, the preferred dRPM solution for hospitals, physicians, community paramedics and provincial health authorities across Canada. With this announcement, our mission to make health care better for everyone in Canada takes another giant stride forward."

About Cloud Dx Inc.

Accelerating digital health care, Cloud Dx is on a mission to make health care better for everyone. Its Connected Health remote patient monitoring platform is used by health care enterprises and care teams across North America to virtually manage chronic disease, enable aging in place and deliver hospital-quality postsurgical care in the home. The company's partners achieve better health care and patient outcomes, reduce the need for hospitalization or readmission, and reduce health care delivery costs through more efficient use of resources. Cloud Dx is the co-winner of the Qualcomm Tricorder XPrize, winner of 2022 top innovator from Canadian Business, a 2021 Edison award winner, a Fast Company world-changing idea finalist and one of Canada's 10 most prominent telehealth providers. Cloud Dx is an exclusive partner to Medtronic Canada, Teladoc Health Canada and leading hospital procurement agent Mohawk Medbuy.

(1) "Post-discharge after surgery Virtual Care with Remote Automated Monitoring-1 (PVC-RAM-1) technology versus standard care: randomized controlled trial." British Medical Journal, September, 2021.

We seek Safe Harbor.